Contribute Try STAT+ Today

Hello, everyone, and nice to see you again after taking an extended weekend break. Nothing like a little time away from the laptop, yes? But alas, the usual routine of online calls and deadlines has, not surprisingly, returned. But what can you do? The world keeps spinning, after all. So we are firing up the coffee kettle and brewing a fresh cup of stimulation to fortify our nerves. Our choice today is cinnamon hazelnut, for those tracking the pantry contents. Meanwhile, here are a few tidbits to get you started. Hope you have a smashing day, and do stay in touch. …

The Biden administration has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Trump as a key strategy to control costs, NPR tells us. Six states have passed laws to start such programs, and Florida, Colorado and New Mexico are the furthest along in plans to get federal approval. The Biden administration said states still have several hurdles to get through, including a review by the Food and Drug Administration, and the efforts may face pressures from the Canadian government.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.